On the basis of protein expression patterns, we have defined high expression of Sox2 (Sox2high) and of EpCAM (measured using antibodies against the extracellular domain EpEX; EpEXhigh) as prognostic factors for improved clinical outcome of HNSCC. This evidence concerns the gene EPCAM and head and neck squamous cell carcinoma.